Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
lung cancer treatment
Jun 18, 2024, 03:23 |
Blog
Herbert Loong: Rick Haas kicking off our CUHK Sarcoma Masterclass in Hong Kong
Herbert Loong shared a post on X: “Prof Rick Haas kicking off our CUHK Medicine CUHK…
Jun 18, 2024, 02:48 |
Blog
Herbert Loong: Tom Wei-Wu Chen on Novel Systemic Therapeutic Strategies for rare sarcomas
Herbert Loong shared a post on X: “Always thrilled to have my good friend and colleague…
Jun 17, 2024, 16:45 |
Cancer Types
Osteosarcoma: What patients should know about
Introduction, what is osteosarcoma? Osteosarcoma is a type of bone cancer that typically affects children…
Jun 17, 2024, 15:55 |
Blog
Douglas Flora: If you don’t know about ACCC, it is time
Douglas Flora shared on LinkedIn: . "Another great trip to Washington:…
Jun 17, 2024, 15:06 |
Dialogues
Oncodaily Dialogues #9 István Peták/ Hosted by Roupen Odabashian
In our ongoing series called “OncoDaily Dialogues”, we consistently feature prominent individuals in the field of…
Jun 17, 2024, 14:25 |
Insight
Myeloma Paper of the Day, June 17th, suggested by Robert Orlowski
Robert Orlowski shared on X: “Myeloma Paper of the Day: Linvoseltamab BCMA TCE (B-cell maturation antigen,…
Jun 17, 2024, 12:35 |
Blog
Herbert Loong: CTOS24 abstract submission deadline has been extended to June 24
Herbert Loong shared on LinkedIn: "Attention All Sarcoma folks! Connective Tissue Oncology Society. CTOS24 abstract submission…
Jun 16, 2024, 13:37 |
Drugs
Stephen Liu: FDA approves repotrectinib for NTRK fusion positive solid tumors
Stephen Liu recently shared a post on X: “FDA approves repotrectinib for NTRK fusion positive…
Jun 16, 2024, 10:46 |
Blog
Mallinckrodt is partnering with admedicum
Lung Cancer Europe shared on X: “Mallinckrodt, a patient-focused pharmaceutical company, is partnering with admedicum, a…
Jun 16, 2024, 09:13 |
Insight
Estela Rodriguez: Subcutaneous vs IV Amivantamab + Lazertinib in NSCLC
Estela Rodriguez shared on X/Twitter: "PALOMA3 Subq (SC) vs IV Amivantamab + Lazertinib, in Refractory EGFR+…
66
67
68
69
70
All:
858
Posts:
671 - 680
Agenus CEO Dr. Garo Armen Honored with WITSA Eminent Person 2024 Award for Cancer Immunotherapy Breakthrough
Vivek Subbiah: Key publications leading to Nobel Prize 2024, published in 1993
Victor Ambros and Gary Ruvkun Awarded 2024 Nobel Prize in Medicine for MicroRNA Discovery
Dr. Zainab Shinkafi-Bagudu: Advocating for Equity in Cancer Care - UICC Presidential Candidacy
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube